Literature DB >> 6166253

Chemotherapy of viral infections.

D A Stringfellow.   

Abstract

As indicated in Table 1, two approaches have been taken to the development of antiviral chemotherapeutic agents. Both have met with some success although the availability of effective chemotherapeutic agents for the treatment of virus infections is very limited. This situation should change in the near future as more specific, direct inhibitors of virus replication are identified and better ways are developed for stimulating specific and nonspecific host defense mechanisms although the discussion of host defenses centered upon the interferon system, there are a variety of other nonspecific host defense mechanisms that are also important including macrophages, lymphocyte subpopulations, and other as yet poorly defined soluble mediators.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166253     DOI: 10.1007/BF00408224

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  17 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

2.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release.

Authors:  A Billiau; V G Edy; H Sobis; P de Somer
Journal:  Int J Cancer       Date:  1974-09-15       Impact factor: 7.396

4.  Differential effects of actinomycin D and puromycin on the release of interferon induced by double stranded RNA.

Authors:  J Vilcek; T G Rossman; F Varacalli
Journal:  Nature       Date:  1969-05-17       Impact factor: 49.962

5.  Molecular basis of interferon action: inhibition of viral RNA translation.

Authors:  P I Marcus; J M Salb
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

6.  Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166).

Authors:  D A Stringfellow; S d Weed
Journal:  Am J Vet Res       Date:  1977-12       Impact factor: 1.156

7.  Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.

Authors:  D A Stringfellow; E R Kern; D K Kelsey; L A Glasgow
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

8.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

9.  Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.

Authors:  E Katz; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

10.  Prophylactic control of simian hemorrhagic fever in monkeys by an interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine.

Authors:  H B Levy; W London; D A Fuccillo; S Baron; J Rice
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

View more
  1 in total

1.  Deoxythymidine pools in animal and human skin with reference to antiviral drugs.

Authors:  J Harmenberg; G Abele; M Malm
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.